|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Biomimetic Therapeutics, Inc. (BMTI) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
28,001,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
250,541 |
Avg
Vol: |
116,764 |
| 52
Week Range: |
$9.49 - $9.49 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Douglas Earl Martin |
General Counsel |
• – – |
2011-10-10 |
4 |
AS |
$2.97 |
$8,911 |
D/D |
(3,000) |
69,144 |
|
- |
|
| Douglas Earl Martin |
General Counsel |
• – – |
2011-10-07 |
4 |
AS |
$3.02 |
$9,047 |
D/D |
(3,000) |
72,144 |
|
- |
|
| Douglas Earl Martin |
General Counsel |
• – – |
2011-10-06 |
4 |
AS |
$2.99 |
$8,965 |
D/D |
(3,000) |
75,144 |
|
- |
|
| Douglas Earl Martin |
General Counsel |
• – – |
2011-10-05 |
4 |
AS |
$2.95 |
$8,836 |
D/D |
(3,000) |
78,144 |
|
- |
|
| Douglas Earl Martin |
General Counsel |
• – – |
2011-10-04 |
4 |
AS |
$2.89 |
$8,678 |
D/D |
(3,000) |
81,144 |
|
- |
|
| Douglas Earl Martin |
General Counsel |
• – – |
2011-10-03 |
4 |
AS |
$2.92 |
$8,756 |
D/D |
(3,000) |
84,144 |
|
- |
|
| Papasan Larry W |
Director |
– • – |
2011-06-10 |
4 |
S |
$5.68 |
$37,036 |
D/D |
(6,500) |
20,381 |
|
- |
|
| Pagano Russell P. |
VP, Reg. & Clinical Affairs |
• – – |
2011-05-19 |
4 |
B |
$7.95 |
$15,104 |
D/D |
1,900 |
5,108 |
2.74 |
- |
|
| Lynch Samuel Eugene |
President and CEO |
• • – |
2011-05-18 |
4 |
B |
$7.75 |
$102,250 |
D/D |
13,000 |
898,912 |
2.81 |
- |
|
| Friedlaender Gary E |
Director |
– • – |
2011-04-25 |
4 |
OE |
$7.96 |
$59,700 |
D/D |
7,500 |
28,995 |
|
- |
|
| Pagano Russell P. |
VP, Reg. & Clinical Affairs |
• – – |
2011-01-25 |
4 |
AS |
$13.32 |
$10,272 |
D/D |
(771) |
3,158 |
|
- |
|
| Lynch Samuel Eugene |
President and CEO |
• • – |
2010-12-31 |
4 |
GA |
$0.00 |
$0 |
I/I |
100,000 |
254,341 |
|
- |
|
| Lynch Samuel Eugene |
President and CEO |
• • – |
2010-12-31 |
4 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
882,220 |
|
- |
|
| Lynch Samuel Eugene |
President and CEO |
• • – |
2010-12-31 |
4 |
GD |
$0.00 |
$0 |
I/I |
50 |
154,341 |
|
- |
|
| Lynch Samuel Eugene |
President and CEO |
• • – |
2010-12-31 |
4 |
GA |
$0.00 |
$0 |
D/D |
50 |
982,220 |
|
- |
|
| Lynch Samuel Eugene |
President and CEO |
• • – |
2010-12-30 |
4 |
OE |
$3.63 |
$95,288 |
D/D |
26,250 |
982,170 |
|
- |
|
| Lynch Samuel Eugene |
President and CEO |
• • – |
2010-12-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
15,100 |
154,391 |
|
- |
|
| Lynch Samuel Eugene |
President and CEO |
• • – |
2010-12-29 |
4 |
GA |
$0.00 |
$0 |
D/D |
15,100 |
955,920 |
|
- |
|
| Bullock Lawrence E |
Chief Financial Officer |
• – – |
2010-12-03 |
4 |
OE |
$3.63 |
$136,125 |
D/D |
37,500 |
65,620 |
|
- |
|
| Pagano Russell P. |
VP, Reg. & Clinical Affairs |
• – – |
2010-10-18 |
4 |
S |
$12.20 |
$22,321 |
D/D |
(1,829) |
3,096 |
|
- |
|
| Lynch Samuel Eugene |
President and CEO |
• • – |
2010-09-09 |
4 |
GD |
$0.00 |
$0 |
I/I |
102,130 |
169,491 |
|
- |
|
| Lynch Samuel Eugene |
President and CEO |
• • – |
2010-09-09 |
4 |
GA |
$0.00 |
$0 |
D/D |
102,130 |
940,820 |
|
- |
|
| Murphy James G |
Director |
– • – |
2010-09-07 |
4 |
OE |
$3.63 |
$35,284 |
D/D |
9,720 |
18,228 |
|
- |
|
| Friedlaender Gary E |
Director |
– • – |
2010-08-23 |
4 |
OE |
$3.63 |
$37,208 |
D/D |
10,250 |
21,495 |
|
- |
|
| Papasan Larry W |
Director |
– • – |
2010-08-23 |
4 |
OE |
$3.63 |
$35,284 |
D/D |
9,720 |
26,881 |
|
- |
|
230 Records found
|
|
Page 3 of 10 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
